Post-translational Control of Intracellular Pathogen Sensing Pathways

Trends in Immunology

Volumn 38, Issue 1, 2017, Pages 39-52

  Chiang, Cindy ^a   Gack, Michaela U ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CHEMOKINE; CYCLIC GMP AMP SYNTHASE; INTERFERON GAMMA INDUCIBLE PROTEIN 16; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MITOCHONDRIAL PROTEIN; PEPTIDES AND PROTEINS; POLYUBIQUITIN; RECEPTOR; RETINOIC ACID INDUCIBLE GENE I LIKE RECEPTOR; STIMULATOR OF INTERFERON GENE PROTEIN; SYNTHETASE; UBIQUITIN LIKE PROTEIN; UNCLASSIFIED DRUG; CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE; CYCLIC NUCLEOTIDE; IFI16 PROTEIN, HUMAN; NUCLEAR PROTEIN; PATTERN RECOGNITION RECEPTOR; PHOSPHOPROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I;

DEAMINATION; ENZYME REGULATION; GLUTAMYLATION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN ACETYLATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SENSOR; UBIQUITINATION; VIRUS LOAD; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; DEAD BOX PROTEIN 58; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTRACELLULAR SPACE; NUCLEAR PROTEINS; NUCLEOTIDES, CYCLIC; PHOSPHOPROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 85006778548     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.10.008     Document Type: Review

References (92)

1. 1 Goubau, D., et al. Cytosolic sensing of viruses. Immunity 38 (2013), 855–869.
2. 2 Wu, J., Chen, Z.J., Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32 (2014), 461–488.
3. 3 Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
4. 4 Dempsey, A., Bowie, A.G., Innate immune recognition of DNA: a recent history. Virology 479-480 (2015), 146–152.
5. 5 Schlee, M., Master sensors of pathogenic RNA – RIG-I like receptors. Immunobiology 218 (2013), 1322–1335.
6. 6 Vazquez, C., Horner, S.M., MAVS coordination of antiviral innate immunity. J. Virol. 89 (2015), 6974–6977.
7. 7 Liu, H.M., et al. The mitochondrial targeting chaperone 14-3-3ɛ regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11 (2012), 528–537.
8. 8 Ishikawa, H., Barber, G.N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 (2008), 674–678.
9. 9 Sun, L., et al. Cyclic GMP–AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339 (2013), 786–791.
10. 10 Unterholzner, L., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11 (2010), 997–1004.
11. 11 Gack, M.U., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007), 916–920.
12. 12 Gack, M.U., et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 16743–16748.
13. 13 Peisley, A., et al. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509 (2014), 110–114.
14. 14 Jiang, X., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36 (2012), 959–973.
15. 15 Sanchez, J.G., et al. Mechanism of TRIM25 catalytic activation in the antiviral RIG-I pathway. Cell Rep. 16 (2016), 1315–1325.
16. 16 Sanchez, J.G., et al. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 2494–2499.
17. 17 Wu, B., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152 (2013), 276–289.
18. 18 del Toro Duany, Y., et al. MDA5-filament, dynamics and disease. Curr. Opin. Virol. 12 (2015), 20–25.
19. 19 Gack, M.U., et al. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84 (2010), 3220–3229.
20. 20 Nistal-Villan, E., et al. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J. Biol. Chem. 285 (2010), 20252–20261.
21. 21 Wies, E., et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38 (2013), 437–449.
22. 22 Maharaj, N.P., et al. Conventional protein kinase C-alpha (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction. J. Virol. 86 (2012), 1358–1371.
23. 23 Sun, Z., et al. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85 (2011), 1036–1047.
24. 24 Takashima, K., et al. RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response. Cell Rep. 11 (2015), 192–200.
25. 25 Arimoto, K-I., et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 7500–7505.
26. 26 Hao, Q., et al. A non-canonical role of the p97 complex in RIG-I antiviral signaling. EMBO J. 34 (2015), 2903–2920.
27. 27 Wang, W., et al. RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation. Proc. Natl. Acad. Sci. U.S.A. 113 (2016), 9581–9586.
28. 28 Wang, L., et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J. Virol. 87 (2013), 4507–4515.
29. 29 Pauli, E-K., et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci. Signal., 7, 2014, ra3.
30. 30 Kim, M.J., et al. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82 (2008), 1474–1483.
31. 31 Mi, Z., et al. SUMOylation of RIG-I positively regulates the type I interferon signaling. Protein Cell 1 (2010), 275–283.
32. 32 Fu, J., et al. MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling. Mol. Immunol. 48 (2011), 415–422.
33. 33 Nguyen, N.T., et al. Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform. Sci. Rep., 6, 2016, 23377.
34. 34 Choi, S.J., et al. HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I. EMBO J. 35 (2016), 429–442.
35. 35 Liu, H.M., et al. Regulation of retinoic acid inducible gene-I (RIG-I) activation by the histone deacetylase 6. EBioMedicine 9 (2016), 195–206.
36. 36 He, S., et al. Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production. Mol. Cell 58 (2015), 134–146.
37. 37 Paz, S., et al. Ubiquitin-regulated recruitment of IκB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29 (2009), 3401–3412.
38. 38 Yoo, Y.S., et al. The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling. Nat. Commun., 6, 2015, 7910.
39. 39 Yang, B., et al. Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J. Immunol. 190 (2013), 3613–3619.
40. 40 Liu, S., et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science, 347, 2015, aaa2630.
41. 41 Song, T., et al. c-Abl tyrosine kinase interacts with MAVS and regulates innate immune response. FEBS Lett. 584 (2010), 33–38.
42. 42 Wen, C., et al. Identification of tyrosine-9 of MAVS as critical target for inducible phosphorylation that determines activation. PLoS One, 7, 2012, e41687.
43. 43 Seo, G.J., et al. Akt kinase-mediated checkpoint of cGAS DNA sensing pathway. Cell Rep. 13 (2015), 440–449.
44. 44 Xia, P., et al. Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity. Nat. Immunol. 17 (2016), 369–378.
45. 45 Li, T., et al. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 10558–10563.
46. 46 Ansari, M.A., et al. Herpesvirus genome recognition induced acetylation of nuclear IFI16 is essential for its cytoplasmic translocation, inflammasome and IFN-β responses. PLoS Pathog., 11, 2015, e1005019.
47. 47 Tsuchida, T., et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33 (2010), 765–776.
48. 48 Zhang, J., et al. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination. J. Biol. Chem. 287 (2012), 28646–28655.
49. 49 Wang, Q., et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 41 (2014), 919–933.
50. 50 Zhong, B., et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30 (2009), 397–407.
51. 51 Qin, Y., et al. RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms. PLoS Pathog., 10, 2014, e1004358.
52. 52 Luo, W.W., et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat. Immunol. 17 (2016), 1057–1066.
53. 53 Tanaka, Y., Chen, Z.J., STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal., 5, 2012, ra20.
54. 54 Konno, H., et al. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155 (2013), 688–698.
55. 55 Li, Z., et al. PPM1A regulates antiviral signaling by antagonizing TBK1-mediated STING phosphorylation and aggregation. PLoS Pathog., 11, 2015, e1004783.
56. 56 Wang, F., et al. S6K–STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3. Nat. Immunol. 17 (2016), 514–522.
57. 57 Barrat, F.J., et al. Importance of nucleic acid recognition in inflammation and autoimmunity. Annu. Rev. Med. 67 (2016), 323–336.
58. 58 Oshiumi, H., et al. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J. Biol. Chem. 284 (2009), 807–817.
59. 59 Oshiumi, H., et al. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog., 9, 2013, e1003533.
60. 60 Oshiumi, H., et al. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8 (2010), 496–509.
61. 61 Yan, J., et al. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J. Mol. Cell Biol. 6 (2014), 154–163.
62. 62 Kuniyoshi, K., et al. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 5646–5651.
63. 63 Inn, K-S., et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41 (2011), 354–365.
64. 64 Wang, Y., et al. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J. Immunol. 189 (2012), 5304–5313.
65. 65 Pan, Y., et al. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation. J. Immunol. 192 (2014), 4758–4764.
66. 66 Zhong, B., et al. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J. Immunol. 184 (2010), 6249–6255.
67. 67 You, F., et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10 (2009), 1300–1308.
68. 68 Cui, J., et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 24 (2014), 400–416.
69. 69 Friedman, C.S., et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9 (2008), 930–936.
70. 70 Lin, W., et al. Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD. Nat. Commun., 7, 2016, 11848.
71. 71 Fan, Y., et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J. Exp. Med. 211 (2014), 313–328.
72. 72 Swatek, K.N., Komander, D., Ubiquitin modifications. Cell Res. 26 (2016), 399–422.
73. 73 Yau, R., Rape, M., The increasing complexity of the ubiquitin code. Nat. Cell Biol. 18 (2016), 579–586.
74. 74 Iwai, K., et al. Linear ubiquitin chains: NF-κB signalling, cell death and beyond. Nat. Rev. Mol. Cell Biol. 15 (2014), 503–508.
75. 75 Walczak, H., et al. Generation and physiological roles of linear ubiquitin chains. BMC Biol., 10, 2012, 23.
76. 76 Ozato, K., et al. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8 (2008), 849–860.
77. 77 Rajsbaum, R., et al. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J. Mol. Biol. 426 (2014), 1265–1284.
78. 78 Versteeg, G.A., et al. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 38 (2013), 384–398.
79. 79 Davis, M.E., Gack, M.U., Ubiquitination in the antiviral immune response. Virology 479-480, 2015, 52–65.
80. 80 Mallery, D.L., et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 19985–19990.
81. 81 McEwan, W.A., et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14 (2013), 327–336.
82. 82 Hatakeyama, S., TRIM proteins and cancer. Nature Rev. Cancer 11 (2011), 792–804.
83. 83 Kimura, T., et al. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J. Cell Biol. 210 (2015), 973–989.
84. 84 Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 14 (2016), 360–373.
85. 85 Gack, M.U., et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5 (2009), 439–449.
86. 86 Rajsbaum, R., et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog, 8, 2012, e1003059.
87. 87 Manokaran, G., et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350 (2015), 217–221.
88. 88 Davis, M.E., et al. Antagonism of the phosphatase PP1 by the measles virus V protein is required for innate immune escape of MDA5. Cell Host Microbe 16 (2014), 19–30.
89. 89 Mesman, A.W., et al. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 16 (2014), 31–42.
90. 90 Chen, W., et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152 (2013), 467–478.
91. 91 Shi, C.S., et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J. Immunol. 193 (2014), 3080–3089.
92. 92 Dell'Oste, V., et al. Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage. J. Virol. 88 (2014), 6970–6982.